Cardiac Pacemakers, Inc.

Cardiac Pacemakers, Inc.
Name	Cardiac Pacemakers, Inc.
Founded	1971
Founder	Wilson Greatbatch
Fate	Acquired (see Legacy and Acquisition)
Headquarters	Norwood, Ohio
Industry	Medical devices
Products	Cardiac pacemakers, pulse generators

Cardiac Pacemakers, Inc. was an American medical device manufacturer established in the early 1970s that produced implantable cardiac rhythm management devices. The company operated in the context of advances pioneered by inventors and institutions such as Wilson Greatbatch, Medtronic, St. Jude Medical, Biotronik, and Johnson & Johnson. Its work intersected with clinical centers including Cleveland Clinic, Mayo Clinic, Johns Hopkins Hospital, and regulatory agencies like the Food and Drug Administration and international regulators.

History

Cardiac Pacemakers, Inc. was founded during a period of rapid development in biomedical engineering influenced by research at Dartmouth College, University of Minnesota, Stanford University, Massachusetts General Hospital, and Imperial College London. Early corporate activity reflected interactions with industry peers such as Medtronic and Boston Scientific, and academic collaborators including Harvard Medical School, University of Pennsylvania, and University of California, San Francisco. The company’s timeline paralleled milestones like the implantation milestones at Johns Hopkins Hospital and technological advances reported at conferences hosted by organizations such as the Heart Rhythm Society and American College of Cardiology.

Products and Innovations

The company manufactured implantable pulse generators and lead systems that competed with offerings from St. Jude Medical, Biotronik, Sorin Group, and Vitatron. Device design incorporated components from suppliers and innovators like Texas Instruments, Philips, Siemens, and materials research from DuPont and 3M. Product lines evolved amid industry trends exemplified by the miniature pacemaker work at Nihon Kohden, the rate-responsive pacing developments at University of Oxford, and the rechargeable systems studied at Massachusetts Institute of Technology.

Corporate Structure and Ownership

Corporate governance drew on models practiced by multinational firms such as General Electric, Siemens AG, Johnson & Johnson, and Baxter International. Investors and boards included individuals with ties to venture capital firms and institutions like Kleiner Perkins, Sequoia Capital, and university endowments from Yale University and Princeton University. Strategic alliances and distribution networks involved partners resembling Arrow International, GE Healthcare, and Becton Dickinson.

Clinical Impact and Adoption

Devices were adopted in clinical practice at centers including Cleveland Clinic, Mayo Clinic, Mount Sinai Hospital (New York City), and Royal Brompton Hospital. Peer-reviewed clinical evaluations appeared alongside studies from research groups at Columbia University, University College London, Karolinska Institutet, and Monash University. Adoption was influenced by comparative trials similar to those published in journals associated with American Heart Association, European Society of Cardiology, and trials run under protocols like those at National Institutes of Health.

Legal and Regulatory Issues

Regulatory oversight involved submissions to the Food and Drug Administration, conformity assessments aligned to directives from the European Medicines Agency, and standards referenced from International Organization for Standardization committees and Underwriters Laboratories. The company navigated litigation environments similar to cases involving Medtronic, Abbott Laboratories, and Boston Scientific, and compliance expectations from agencies such as Centers for Medicare & Medicaid Services and national health authorities in Canada and Australia.

Research and Development

R&D activities collaborated with academic laboratories at Massachusetts Institute of Technology, Stanford University, University of California, San Diego, and Karolinska Institutet, and were presented at meetings of the Heart Rhythm Society, European Heart Rhythm Association, and American College of Cardiology. Engineering work paralleled signal processing research from Bell Labs, biomaterials work at MIT Media Lab, and battery chemistry advances involving Exide Technologies and academic partners at University of Cambridge.

Legacy and Acquisition

The company’s intellectual property, product lines, and facilities entered consolidation trends characteristic of mergers such as Medtronic–Guidant and Johnson & Johnson acquisitions of device makers. Legacy assets and patents were integrated into larger portfolios resembling those of Medtronic, Abbott Laboratories, Boston Scientific, and St. Jude Medical. Its operational footprint in Norwood, Ohio influenced regional industry clusters similar to those seen around Minneapolis, Boston, and Silicon Valley.

Category:Medical device companies Category:Defunct companies of the United States